Showing results (131-140 of 182) with videos related to

Sort By:
Pageof 19
Journal of Family Medicine and Primary Care|December 12, 2022
Assessing the SpO2 in a random population - Looking for the best among fingersPrabhat Agrawal, Nikhil Pursnani, Ashish Gautam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2015
SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung CancerErica Hlavin Bell, Arup R Chakraborty, Xiaokui Mo, et al.
Cancer Control : Journal of the Moffitt Cancer Center|October 29, 2003
Gefitinib (ZD1839) in previously treated advanced non-small-cell lung cancer: experience from a single institutionGeorge R Simon, John C Ruckdeschel, Charles Williams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2010
Phase I/II study of the Src inhibitor dasatinib in combination with erlotinib in advanced non-small-cell lung cancerEric B Haura, Tawee Tanvetyanon, Alberto Chiappori, et al.
Journal of Mid-Life Health|March 26, 2021
COVID-19 Outcomes in Postmenopausal and Perimenopausal Females: Is Estrogen Hormone Attributing to Gender Differences?Ruchika Garg, Prabhat Agrawal, Ashish Gautam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Phase I/II study of atrasentan, an endothelin A receptor antagonist, in combination with paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancerAlberto A Chiappori, Eric Haura, Francisco A Rodriguez, et al.
Oncotarget|July 25, 2018
A CARP-1 functional mimetic compound is synergistic with BRAF-targeting in non-small cell lung cancersVino T Cheriyan, Hashem Alsaab, Sreeja Sekhar, et al.
Ophthalmic Research|November 6, 2010
Macrophages acquire fibroblast characteristics in a rat model of proliferative vitreoretinopathyMiao-li Lin, Yong-ping Li, Zhan-rong Li, et al.
Pageof 19